Does IMATINIB Cause Haemoglobin decreased? 646 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 646 reports of Haemoglobin decreased have been filed in association with IMATINIB (Imatinib). This represents 1.5% of all adverse event reports for IMATINIB.
646
Reports of Haemoglobin decreased with IMATINIB
1.5%
of all IMATINIB reports
227
Deaths
282
Hospitalizations
How Dangerous Is Haemoglobin decreased From IMATINIB?
Of the 646 reports, 227 (35.1%) resulted in death, 282 (43.7%) required hospitalization, and 48 (7.4%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 646 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which IMATINIB Alternatives Have Lower Haemoglobin decreased Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL